The DOI matches its Crossref record; 36 of the 37 references it cites were found in a registry or an index.
TSH‐receptor antibody measurement for differentiation of hyperthyroidism into Graves' disease and multinodular toxic goitre: a comparison of two competitive binding assays
Abstract
OBJECTIVES Graves' disease is characterized by stimulating autoantibodies to the TSH‐receptor (TRAb). The aim of this study was to compare the performance of a new TRAb assay based on competitive binding to recombinant human TSH‐receptors (H‐TRAb) with an assay employing purified porcine TSH‐receptors (P‐TRAb). Furthermore, to evaluate the applicability of the H‐TRAb assay to discriminate between patients with hyperthyroidism due to Graves' disease (GD) and multinodular toxic goitre (MNTG). DESIGN AND MEASUREMENTS H‐TRAb and P‐TRAb were measured in patients with newly diagnosed hyperthyroidism due to GD (n = 106) and MNTG (n = 94). For comparison, TRAb was measured in patients with primary autoimmune hypothyroidism, euthyroid subjects with an enlarged thyroid gland by ultrasound, and healthy controls (n = 100 for each group). Patients were consecutively included from a population survey. RESULTS If the cut‐off values recommended by the manufacturer for TSH‐receptor antibody positivity were used for evaluation, the sensitivity of the H‐TRAb assay vs. the P‐TRAb assay in diagnosing GD was: 95·3/67·9% (P < 0·001). Specificity was (H/P‐TRAb): 99/99%. The sensitivity of P‐TRAb was increased if the upper 97·5% limit of measurements in controls was used as cut‐off (H‐TRAb vs. P‐TRAb: 95·3/80·2%, P < 0·001). Specificity (H/P‐TRAb): 98/98%. The difference between assay performance may partly be due to a better technical performance of the H‐TRAb assay with more reliable results in the low range of measurements. However, even in GD patients with clearly measurable TRAb, 25% had a P‐TRAb < 50% of the value expected from the H‐TRAb measurement. This suggests that a subgroup of patients produce TRAb with a higher affinity for the human than the porcine TSH receptor. A relatively high proportion of patients with MNTG were TRAb positive (H‐TRAb/P‐TRAb: 17/9%). Characteristics of H‐TRAb positive and negative MNTG patients were compared. There was no difference between size of thyroid gland and number of nodules by ultrasonography. H‐TRAb positive patients had significantly higher serum T4 and T3 and a greater number were TPO‐Ab positive. CONCLUSIONS H‐TRAb diagnosed Graves' disease with a high sensitivity and specificity than P‐TRAb. The high occurrence of TRAb in multinodular toxic goitre might in part reflect an overlap between Graves' disease and multinodular toxic goitre in some patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, TSH receptor autoantibodies can identify autoimmunity even in nodular glands because approximately 17% of patients in iodine-deficient areas with scintigraphic criteria for toxic MNG may be positive for TSH receptor autoantibodies [28] .”
From The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism (2015) · cites this paper as [28]
In the citing paper
“Additionally, GD and nontoxic nodular goiter may coincide, resulting in positive TRAb levels and a nodular ultrasound or heterogeneous uptake images (47).”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [47]
In the citing paper
“Approximately 5% of patients with newly diagnosed Graves' hyperthyroidism are TRAb negative in older assays (47,455), and 3% are negative in third-generation assays ( 57), especially those with milder disease.”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [47]
In the citing paper
“TRAb measurement is useful in the diagnosis of GD in pregnant women with newly diagnosed hyperthyroidism who do not have clinical signs specific for GD, keeping in mind that the diagnostic sensitivity of good assays is around 95% and the specificity is 99% (47).”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [47]
In the citing paper
“TRAb measurement is useful in the diagnosis of GD in pregnant women with newly diagnosed hyperthyroidism who do not have clinical signs specific for GD, keeping in mind that the diagnostic sensitivity of good assays is around 95% and the specificity is 99% (47).”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [47]
Citations
Cites
STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT
Martin Bland, J., & Altman, D. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90837-8 · Cited by 47,965
Beckett, A. H., Rowland, M., & TURNER, P. (1965) · The Lancet · doi:10.1016/s0140-6736(65)91037-8 · Cited by 16,917
Autoantibodies to the Thyrotropin Receptor
Smith, B. R., McLachlan, S. M., & Furmaniak, J. (1988) · Endocrine Reviews · doi:10.1210/edrv-9-1-106 · Cited by 578
Spencer, C. A., Takeuchi, M., Kazarosyan, M., Wang, C. C., Guttler, R., SINGER, P. A., Fatemi, S., LoPresti, J. S., & Nicoloff, J. T. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.4.4683 · Cited by 476
Laurberg, P., Pedersen, K. M., Hreiðarsson, Á. B., Sigfússon, N., Iversen, E., & Knudsen, P. R. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.3.4624 · Cited by 399
Self-citationSpencer, C. A. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.4.1121 · Cited by 385
LAURBERG, P., PEDERSEN, K. M., VESTERGAARD, H., & SIGURDSSON, G. (1991) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1991.tb00368.x · Cited by 361
Self-citationCostagliola, S., Morgenthaler, N. G., Hoermann, R., Badenhoop, K. W. J., Struck, J., Freitag, D., Poertl, S., Weglöhner, W., Hollidt, J. M., Quadbeck, B., et al. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.1.5415 · Cited by 341
Laurberg, P., Nygaard, B., Glinoer, D., Grussendorf, M., & Orgiazzi, J. (1998) · European Journal of Endocrinology · doi:10.1530/eje.0.1390584 · Cited by 191
Self-citationKnudsen, N. J., Bülow, I., Jørgensen, T., Laurberg, P., Ovesen, L., & Perrild, H. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.01121.x · Cited by 165
Self-citation
Research works printed but not linked: 7
- Bech K., 1983, Immunological aspects of Graves' disease and importance of thyroid stimulating immunoglobulins. Thesis, Acta Endocrinologia, 103, 1
- 10.1210/jc.84.1.90 · DOI
- 10.1210/jc.83.11.3777 · DOI
- 10.1210/jc.79.1.134 · DOI
- Meller J., 2000, Clinical implications of a new TSH‐receptor‐antibody assay (DYNOtest® human) in autoimmune thyroid diseases, Nuklearmedizin, 1, 5
- 10.1210/jc.79.6.1785 · DOI
- 10.1210/jc.85.6.2270 · DOI
Cited by
Sorted by citations
Ross, D. S., Burch, H. B., Cooper, D. S., Greenlee, M. C., Laurberg, P., Maia, A. L., Rivkees, S. A., Samuels, M., Sosa, J. A., Stan, M. N., et al. (2016) · Thyroid® · doi:10.1089/thy.2016.0229 · Cited by 2,938
“Additionally, GD and nontoxic nodular goiter may coincide, resulting in positive TRAb levels and a nodular ultrasound or heterogeneous uptake images (47).”
BackgroundSelf-citationGharib, H., Papini, E., Garber, J. R., Duick, D. S., Harrell, R. M., Hegedűs, L. D., Paschke, R., Valcavi, R., & Vitti, P. (2016) · Endocrine Practice · doi:10.4158/ep161208.gl · Cited by 1,285
Smith, T. J., & Hegedűs, L. D. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1510030 · Cited by 1,338
Bahn, R. S., Burch, H. B., Cooper, D. S., Garber, J. R., Greenlee, M. C., Klein, I., Laurberg, P., McDougall, I. R., Montori, V. M., Rivkees, S. A., et al. (2011) · Endocrine Practice · doi:10.4158/ep.17.3.456 · Cited by 1,098
Self-citationGharib, H., Papini, E., Paschke, R., Duick, D. S., Valcavi, R., Hegedűs, L. D., Vitti, P., Gharib, H., Papini, E., Paschke, R., et al. (2010) · Endocrine Practice · doi:10.4158/10024.gl · Cited by 1,087
The American Thyroid Association and American Association of Clinical Endocrinologists Taskforce on Hyperthyroidism and Other Causes of Thyrotoxicosis, Bahn, R. S., Burch, H. B., Cooper, D. S., Garber, J. R., Greenlee, M. C., Klein, I., Laurberg, P., McDougall, I. R., Montori, V. M., et al. (2011) · Thyroid · doi:10.1089/thy.2010.0417 · Cited by 898
Self-citationLaurberg, P., Wallin, G., Tallstedt, L., Abraham-Nordling, M., Lundell, G., & Tørring, O. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0450 · Cited by 428
Self-citationBiondi, B., Bartalena, L., Cooper, D. S., Hegedüs, L., Laurberg, P., & Kahaly, G. J. (2015) · European Thyroid Journal · doi:10.1159/000438750 · Cited by 323
Self-citationClinical Utility of TSH Receptor Antibodies
Barbesino, G., & Tomer, Y. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-4309 · Cited by 237
Weetman, A. P. (2004) · Autoimmunity · doi:10.1080/08916930410001705394 · Cited by 225
Epidemiology of subtypes of hyperthyroidism in Denmark: a population-based study
Carlé, A., Pedersen, I. B., Knudsen, N., Perrild, H., Ovesen, L., Rasmussen, L. B., & Laurberg, P. (2011) · European Journal of Endocrinology · doi:10.1530/eje-10-1155 · Cited by 204
Self-citationTozzoli, R., Bagnasco, M., Giavarina, D., & Bizzaro, N. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2012.07.003 · Cited by 195
Smith, B. R., Sanders, J. F., & Furmaniak, J. (2007) · Thyroid · doi:10.1089/thy.2007.0239 · Cited by 143
Vos, X. G., Smit, N., Endert, E., Tijssen, J. G. P., & Wiersinga, W. M. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03192.x · Cited by 133
Rapoport, B., Alsabeh, R., Aftergood, D., & McLachlan, S. M. (2000) · Thyroid · doi:10.1089/10507250050137761 · Cited by 130
Hypothyroidism in the Elderly: Pathophysiology, Diagnosis and Treatment
Laurberg, P., Andersen, S., Pedersen, I. B., & Carl, A. B. (2005) · Drugs & Aging · doi:10.2165/00002512-200522010-00002 · Cited by 142
Self-citationCarella, C., Mazziotti, G., Sorvillo, F., Piscopo, M., Cioffi, M., Pilla, P., Nersita, R., Iorio, S., Amato, G., Braverman, L. E., et al. (2006) · Thyroid · doi:10.1089/thy.2006.16.295 · Cited by 119
Thyrotoxicosis: Diagnosis and Management
Sharma, A. R., & Stan, M. N. (2019) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2018.10.011 · Cited by 116
Laurberg, P., Berman, D. C., Andersen, S., & Pedersen, I. B. (2011) · Thyroid · doi:10.1089/thy.2011.0039 · Cited by 87
Self-citationMoon, J. H., & Yi, K. H. (2013) · Endocrinology and Metabolism · doi:10.3803/enm.2013.28.4.275 · Cited by 79
Bednarczuk, T., Brix, T. H., Schima, W., Zettinig, G., & Kahaly, G. J. (2021) · European Thyroid Journal · doi:10.1159/000517175 · Cited by 86
Clinical review about TRAb assay's history
Zöphel, K., Roggenbuck, D., & Schott, M. (2010) · Autoimmunity Reviews · doi:10.1016/j.autrev.2010.05.021 · Cited by 77
Scappaticcio, L., Trimboli, P., Keller, F., Imperiali, M., Piccardo, A., & Giovanella, L. (2019) · Clinical Endocrinology · doi:10.1111/cen.14130 · Cited by 76
Schott, M., Hermsen, D. F., Broecker‐Preuss, M., Casati, M., Cámara, J., Eckstein, A. K., Gassner, D., Golla, R., Graeber, C., van Helden, J., et al. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03512.x · Cited by 74
Thyrotropin Receptor Antibodies—An Overview
Kotwal, A., & Stan, M. N. (2018) · Ophthalmic Plastic and Reconstructive Surgery · doi:10.1097/iop.0000000000001052 · Cited by 73
Carlé, A., Pedersen, I. B., Knudsen, N. J., Perrild, H., Ovesen, L., Jørgensen, T., & Laurberg, P. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1370 · Cited by 72
Self-citationMohlin, E., Nyström, H. F., & Eliasson, M. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0811 · Cited by 69
Thyrotropin receptor autoantibodies in Graves' disease
Schott, M., Scherbaum, W. A., & Morgenthaler, N. G. (2005) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2005.05.009 · Cited by 61
Thyrotropin receptor antibodies: new insights into their actions and clinical relevance
Ando, T., Latif, R., & Davies, T. F. (2005) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2004.11.005 · Cited by 62
Relapse following antithyroid drug therapy for Graves’ hyperthyroidism
Laurberg, P., Krejbjerg, A., & Andersen, S. L. (2014) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0000000000000088 · Cited by 60
Self-citationCarlé, A., Knudsen, N., Pedersen, I. B., Perrild, H., Ovesen, L., Rasmussen, L. B., & Laurberg, P. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0533 · Cited by 55
Self-citationKamijo, K. (2007) · Endocrine Journal · doi:10.1507/endocrj.k06-196 · Cited by 54
Assay of Thyroid Hormones and Related Substances
Spencer, C. A. (2013) · Europe PMC (PubMed Central) · Cited by 53
The role of TSH receptor antibodies in the management of Graves' disease
Matthews, D. C., & Syed, A. A. (2011) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2011.02.006 · Cited by 52
Schmidt, M. C., Gorbauch, E., Dietlein, M., Faust, M., Stützer, H., Eschner, W., THEISSEN, P., & Schicha, H. (2006) · Thyroid · doi:10.1089/thy.2006.16.281 · Cited by 47
Dunkelmann, S., Wolf, R., Koch, A., Kittner, C., Groth, P., & Schuemichen, C. (2004) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-004-1519-8 · Cited by 46
ENDOCRINOLOGY IN PREGNANCY: Pregnancy and the incidence, diagnosing and therapy of Graves’ disease
Laurberg, P., & Andersen, S. L. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0410 · Cited by 42
Self-citationMassart, C., Sapin, R., Gibassier, J., Agin, A., & d’Herbomez, M. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2008.115162 · Cited by 40
Hermsen, D. F., Broecker‐Preuss, M., Casati, M., Cámara, J., Eckstein, A. K., Gassner, D., van Helden, J., Inomata, K., Jarausch, J., Kratzsch, J., et al. (2008) · Clinica Chimica Acta · doi:10.1016/j.cca.2008.11.025 · Cited by 38
Liu, C., Hermsen, D. F., Domberg, J., Graeber, C., Hautzel, H., Duan, Y., Xu, K., Liu, C. P., Mao, X., Cupisti, K., et al. (2008) · Hormone and Metabolic Research · doi:10.1055/s-2008-1077051 · Cited by 35
Pedersen, I. B., Handberg, A., Knudsen, N. J., Heickendorff, L., & Laurberg, P. (2010) · Thyroid · doi:10.1089/thy.2009.0105 · Cited by 34
Self-citationThe Diagnosis and Management of Hyperthyroidism Consensus - Report of the Korean Thyroid Association
Yi, K. H., Moon, J. H., Kim, I.-J., Bom, H.-S., Lee, J., Chung, W. Y., Chung, J. H., & Shong, Y. K. (2013) · Journal of Korean Thyroid Association · doi:10.11106/jkta.2013.6.1.1 · Cited by 32
Orunesu, E., Bagnasco, M., Salmaso, C., Altrinetti, V., Bernasconi, D., Monte, P. D., Pesce, G., Marugo, M., & Mela, G. S. (2004) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2004.01318.x · Cited by 30
Villalta, D., Orunesu, E., Tozzoli, R., Montagna, P., Pesce, G., Bizzaro, N., & Bagnasco, M. (2004) · Journal of Clinical Pathology · doi:10.1136/jcp.2003.012294 · Cited by 28
Tozzoli, R., Kodermaz, G., Villalta, D., Bagnasco, M., Pesce, G., & Bizzaro, N. (2010) · Autoimmunity Highlights · doi:10.1007/s13317-010-0014-4 · Cited by 27
Performance of a third‐generation TSH‐receptor antibody in a UK clinic
Theodoraki, A., Jones, G., Parker, J. C., Woolman, E., Martin, N. G., Perera, S., Thomas, M., Bunn, C. F., Khoo, B. C. E., Bouloux, P. M., et al. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04022.x · Cited by 21
Detection of low titre TBII in patients with Graves’ disease using recombinant human TSH receptor
Morgenthaler, N. G., Nagata, A., Katayama, S., Bergmann, A., & Iitaka, M. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01577.x · Cited by 20
Prevalence and Treatment Outcomes of Marine-Lenhart Syndrome in Japan
Danno, H., Nishihara, E., Kousaka, K., Nakamura, T., Kasahara, T., Kudo, T., Ito, M., Fukata, S., Nishikawa, M., & Miyauchi, A. (2020) · European Thyroid Journal · doi:10.1159/000510312 · Cited by 19
Izumi, Y., Takeoka, K., & Amino, N. (2005) · Endocrine Journal · doi:10.1507/endocrj.52.493 · Cited by 19
Antithyroid drug therapy of Graves’ hyperthyroidism: realistic goals and focus on evidence
Laurberg, P., Andersen, S., & Karmisholt, J. (2006) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.1.1.91 · Cited by 17
Self-citationDoroudian, S., Pedersen, I. B., Knudsen, C. S., Handberg, A., & Andersen, S. L. (2017) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365513.2017.1354257 · Cited by 15
Self-citationLaurberg, P., Berman, D. C., Pedersen, I. B., Andersen, S., & Carlé, A. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-4557 · Cited by 16
Self-citationEffects of fission neutrons on human thyroid tissues maintained in SCID mice
Adachi, S., Ryo, H., Hongyo, T., Nakajima, H., Tsuboi-Kikuya, R., Tokita, Y., Matsuzuka, F., Hiramatsu, K., Fujikawa, K., Itoh, T., et al. (2010) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2009.12.017 · Cited by 12
Evaluation of the role of thyroid scintigraphy in the differential diagnosis of thyrotoxicosis
Perdomo, C. M., García‐Goñi, M., Sancho, L., Paricio, J. J., Lozano, M. D., de la Higuera, M., Currás, M., Arbizu, J., & Galofré, J. C. (2020) · Clinical Endocrinology · doi:10.1111/cen.14308 · Cited by 11
Nomura, T., Hongyo, T., Nakajima, H., Li, L. Y., Syaifudin, M., Adachi, S., Ryo, H., Baskar, R., Fukuda, K., Oka, Y., et al. (2008) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2008.08.006 · Cited by 11
John, M., Jagesh, R., Unnikrishnan, H., Jalaja, M. M. N., Oommen, T., & Gopinath, D. (2022) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_388_21 · Cited by 11
Paunković, N., & Paunković, J. (2007) · PubMed · Cited by 10
Improved Sensitivity of a Thyrotropin Receptor Antibody Assay
Jensen, E. A., Petersen, P. H., Blaabjerg, O., Hansen, P. S., & Hegedűs, L. D. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2005.054676 · Cited by 9
Thyrotropin Receptor Antibodies in Early Pregnancy
Torp, N. M. U., Bruun, N. H., Christensen, P. A., Handberg, A., Andersen, S., & Andersen, S. L. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac383 · Cited by 8
Cardia, M., Lima, N., Knobel, M., & Medeiros-Neto, G. A. (2004) · Thyroid · doi:10.1089/105072504323030951 · Cited by 8
Jonas, M. I., Ambroziak, U., Bednarczuk, T., & Nauman, J. A. (2006) · PubMed · Cited by 6
Biological variation in thyroid function tests in older adults and clinical implications
Riis, J., Westergaard, L., Karmisholt, J., Andersen, S. L., & Andersen, S. (2023) · Clinical Endocrinology · doi:10.1111/cen.14973 · Cited by 5
Toxic Adenoma and Multinodular Toxic Goiter
Tonacchera, M., & Führer, D. (2018) · Endocrinology · doi:10.1007/978-3-319-45013-1_18 · Cited by 5
Jonas, M. I., Ambroziak, U., & Nauman, J. A. (2006) · PubMed · Cited by 5
Measurements of TSH receptor antibodies in differential diagnosis
Laurberg, P., & Pedersen, I. B. (2006) · Immuno-analyse & Biologie Spécialisée · doi:10.1016/j.immbio.2006.04.007 · Cited by 5
Self-citationWunderlich, G., Kopprasch, C., Koch, R., Franke, W., Kotzerke, J., & Zöphel, K. (2003) · Nuklearmedizin - NuclearMedicine · doi:10.1055/s-0038-1625298 · Cited by 5
Abdalaziz, A., Vanka, R., Bartholomew, P. H., Vennart, N., Vernazza, J., Stewart, K., Tsatlidis, V., Narayanan, K., Weaver, J. U., & Razvi, S. (2022) · Clinical Endocrinology · doi:10.1111/cen.14709 · Cited by 4
Graves' disease and thyroid functional autonomy in the region of mild iodine deficiency
As, A., Васильевна, К. Л., & Bugova, L. A. (2011) · Clinical and experimental thyroidology · doi:10.14341/ket20117451-55 · Cited by 4
Endocrine and Metabolic Diseases
Yuan, H., Zhao, J., Xie, E., Yi, L., Zheng, Z., & Geng, J. (2021) · Springer eBooks · doi:10.1007/978-981-16-1037-0_40 · Cited by 5
Clinical Applications of Thyrotropin Binding Inhibitor Immunoglobulin (TBII) Assays
Kim, W. B. (2008) · Journal of Korean Endocrine Society · doi:10.3803/jkes.2008.23.3.174 · Cited by 3
Meena, M. Q. (2020) · Open Journal of Endocrine and Metabolic Diseases · doi:10.4236/ojemd.2020.102002 · Cited by 3
Recombinant human thyrotropin (rhTSH)-aided radioiodine treatment for non-toxic multinodular goitre
Huo, Y., Xie, J., Chen, S., Wang, H., & Ma, C. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010622.pub2 · Cited by 3
Paunković, N., & Paunković, J. (2003) · PubMed · Cited by 3
Huh, J. E., Suk, J. H., Kim, M.-K., Choi, I. J., Son, S. M., Kim, I. J., & Kim, Y. K. (2008) · Journal of Korean Endocrine Society · doi:10.3803/jkes.2008.23.3.179 · Cited by 3
Recombinant human thyrotropin (rhTSH) aided radioiodine treatment for non-toxic multinodular goitre
Ma, C., Xie, J., Chen, S., Su, Q., & Wang, H. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010622 · Cited by 2
Thyrotropin receptor antibodies assays in the management of Graves’ disease
Fadeev, V. V. (2013) · Clinical and experimental thyroidology · doi:10.14341/ket2013919-17 · Cited by 2
Khan, N. A., & Singh, M. (2011) · Modern Rheumatology · doi:10.1007/s10165-011-0570-0 · Cited by 2
Aydın, C., Başer, H., Çuhacı, N., Özdemir, D., Yalçin, S., Özdemir, E., Ersoy, R., & Çakır, B. (2020) · Ankara Medical Journal · doi:10.5505/amj.2020.79553 · Cited by 2
Bonnema, S. J., & Hegedűs, L. D. (2018) · Endocrinology · doi:10.1007/978-3-319-45013-1_5 · Cited by 2
Diagnostic Approach and Therapeutic Strategies for Ambiguous Thyrotoxicosis
Kim, M. (2025) · Korean Journal of Medicine · doi:10.3904/kjm.2025.100.5.241 · Cited by 1
The High Proportion of Painless Thyroiditis as a Cause of Thyrotoxicosis in Korea
Mo, S. I., Ryu, A., Kim, Y. J., & Kim, S. J. (2015) · Journal of Korean Thyroid Association · doi:10.11106/cet.2015.8.1.61 · Cited by 1
Schott, M. (2009) · Yearbook of Endocrinology · doi:10.1016/s0084-3741(08)79255-2 · Cited by 1
Toxic Adenoma and Multinodular Toxic Goiter
Tonacchera, M., & Führer, D. (2017) · Endocrinology · doi:10.1007/978-3-319-29195-6_18-1 · Cited by 1
Grave’s Eye Ophthalmopathy Developing Following Radioiodine Therapy for Toxic Adenoma
Ahmadieh, H., & Salti, I. (2013) · Open Journal of Endocrine and Metabolic Diseases · doi:10.4236/ojemd.2013.36035 · Cited by 1
Graves' Disease, Hyperthyroidism in
Prummel, M. F. (2004) · Elsevier eBooks · doi:10.1016/b0-12-475570-4/00563-1 · Cited by 1
Hyperthyroidism in Graves’ Disease
Covelli, D., & Salvi, M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.98496-4 · Cited by 1
Genetic and functional studies on the thyroid hormone axis
Elgadi, A. (2008) · Figshare
Determination of TSH receptor antibodies and its diagnostic worth1
Albrecht, C., Steveling, A., & Wallaschofski, H. (2008) · Journal of Laboratory Medicine · doi:10.1515/jlm.2008.002et
Albrecht, C., Steveling, A., & Wallaschofski, H. (2008) · Journal of Laboratory Medicine · doi:10.1515/jlm.2008.002
Fadeyev, V. V., Abramova, N., Gitel, E. P., Pauncovic, N., Pauncovic, J., Prokofyev, S. A., & Mel'nichenko, G. A. (2006) · Clinical and experimental thyroidology · doi:10.14341/ket20062248-55
Clinical observation of the patient with primary hyperparathyroidism and nodular toxic goiter
Vachev, A. N., Frolova, E. V., Сахипов, Д. Р., & Морковских, Н. В. (2015) · Endocrine Surgery · doi:10.14341/serg2015142-47
Gharib, H., Papini, E., Paschke, R., Duick, D. S., Valcavi, R., Hegedűs, L. D., & Vitti, P. (2010) · University of Southern Denmark Research Portal (University of Southern Denmark)
Schinner, S. (2010) · Yearbook of Endocrinology · doi:10.1016/s0084-3741(10)79470-1
Subclinical hyperthyroidism: diagnostic criteria and principles of treatment
Галицкая, В. В. (2016) · Reproductive Endocrinology · doi:10.18370/2309-4117.2016.30.119-124
Galitskaya, V. V. (2016) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.6.78.2016.81859
Bonnema, S. J., & Hegedűs, L. D. (2022) · doi:10.1093/med/9780198870197.003.0043
Bonnema, S. J., & Hegedűs, L. D. (2017) · Endocrinology · doi:10.1007/978-3-319-29195-6_5-1
Metadata
- Authors
- Pedersen, I. B., Knudsen, N., Perrild, H., Ovesen, L., & Laurberg, P.
- Affiliations
- Aalborg University Hospital (DK)
- Corresponding author
- Pedersen, Inge Bülow
- ORCID
- Knudsen, Nils
- Venue
- Clinical Endocrinology
- Publisher
- Wiley
- Published
- 2001-09
- Volume
- 55
- Issue
- 3
- Pages
- 381-390
- ISSN
- 0300-0664 (ISSN-L)
- 1365-2265
- OpenAlex
- W2133135887
- Cited by
- 108
- References
- 37
- Citations by year
- 2026: 1 · 2025: 3 · 2023: 2 · 2022: 4 · 2021: 3 · 2020: 4 · 2019: 3 · 2018: 4 · 2017: 3 · 2016: 9 · 2015: 5 · 2014: 2 · 2013: 10 · 2012: 1
- FWCI
- 2.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Keywords
- TSH receptor antibodies, Graves' disease, hyperthyroidism, competitive binding assay, antibody affinity, sensitivity and specificity, differential diagnosis, autoimmune hypothyroidism, thyroid autoantibodies, assay comparison, cut-off values, thyroid scintigraphy
- MeSH terms
- Adult, Aged, Animals, Autoantibodies, Binding, Competitive, Cross-Sectional Studies, Diagnosis, Differential, Female, Goiter, Nodular, Graves Disease, Humans, Male, Middle Aged, Radioimmunoassay, Receptors, Thyrotropin, Recombinant Proteins, Registries, Sensitivity and Specificity, Swine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review